-
Piper Sandler's Top Medical Technology Picks Exiting 4Q-25 EPS Season
-
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
-
Sotera Health (SHC) PT Raised to $23 at Citi
-
Sotera Health Co. (SHC) Tops Q4 EPS by 2c ; Offers Guidance
-
KeyBanc on Medical Technology: 'From Reset to Rebound?'
-
Piper Sandler Upgrades Sotera Health (SHC) to Overweight
-
RBC Capital Starts Sotera Health (SHC) at Outperform
-
William Blair Starts Sotera Health (SHC) at Outperform
-
Jefferies Reiterates Buy Rating on Sotera Health (SHC)
-
Sotera Health (SHC) PT Raised to $16 at Jefferies
-
Sotera Health (SHC) PT Raised to $17 at Barclays
-
Sotera Health Co. (SHC) Tops Q2 EPS by 3c ; Offers Guidance
-
Goldman Sachs Upgrades Sotera Health (SHC) to Buy
-
Sotera Health Co. (SHC) Tops Q1 EPS by 2c ; Offers Guidance
-
Sotera Health Co. (SHC) Appoints Vincent K. Petrella as Lead Independent Director
-
Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'
-
Goldman Sachs Starts Sotera Health (SHC) at Neutral
-
Sotera Health (SHC) PT Lowered to $15 at Jefferies
-
Piper Sandler Reiterates Neutral Rating on Sotera Health (SHC)
-
Piper Sandler Reiterates Neutral Rating on Sotera Health (SHC)
-
Sotera Health (SHC) PT Raised to $18 at Jefferies
-
Sotera Health (SHC) PT Raised to $20 at Citi
-
Sotera Health (SHC) PT Raised to $15 at JPMorgan
-
Sotera Health Co. (SHC) Misses Q3 EPS by 1c, Beats on Revenue
-
Sotera Health Co. (SHC) Announces Secondary Offering of Common Stock
-
KeyBanc Reiterates Sector Weight Rating on Sotera Health (SHC)
-
Sotera Health Co. (SHC) call put ratio 2 calls to 1 put as share price up 7.3%
-
Sotera Health Co. (SHC) Tops Q2 EPS by 3c ; Offers Guidance
-
Sotera Health Co. (SHC) Appoints Christopher Simon to its Board

